Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vanguard Research Group (VRG) is a specialized clinical research organization (CRO) and site management organization that focuses on central nervous system (CNS) disorders, particularly in the field of psychiatry. As a non-profit affiliate of Northwell Health and the Feinstein Institutes for Medical Research, VRG bridges the gap between academic innovation and industry-sponsored clinical trials. The organization provides comprehensive trial management services, including protocol development, site selection, regulatory oversight, and data management for large-scale, multi-center studies. VRG is widely recognized for its expertise in serious mental illnesses such as schizophrenia and bipolar disorder, leveraging a robust network of high-performing clinical sites across the United States. By combining deep clinical knowledge with operational excellence, VRG facilitates the development of novel therapeutics and interventions for complex neuropsychiatric conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vanguard Research Group.